These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 32407673)

  • 1. Using Chemical Epigenetics to Target Cancer.
    Wimalasena VK; Wang T; Sigua LH; Durbin AD; Qi J
    Mol Cell; 2020 Jun; 78(6):1086-1095. PubMed ID: 32407673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis targeting chimeras (PROTACs) for epigenetics research.
    Vogelmann A; Robaa D; Sippl W; Jung M
    Curr Opin Chem Biol; 2020 Aug; 57():8-16. PubMed ID: 32146413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidrugs: targeting epigenetic marks in cancer treatment.
    Miranda Furtado CL; Dos Santos Luciano MC; Silva Santos RD; Furtado GP; Moraes MO; Pessoa C
    Epigenetics; 2019 Dec; 14(12):1164-1176. PubMed ID: 31282279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer induction and suppression with transcriptional control and epigenome editing technologies.
    Nakade S; Yamamoto T; Sakuma T
    J Hum Genet; 2018 Feb; 63(2):187-194. PubMed ID: 29215091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cellular metabolism on chromatin dynamics and epigenetics.
    Reid MA; Dai Z; Locasale JW
    Nat Cell Biol; 2017 Nov; 19(11):1298-1306. PubMed ID: 29058720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in epigenetics link genetics to the environment and disease.
    Cavalli G; Heard E
    Nature; 2019 Jul; 571(7766):489-499. PubMed ID: 31341302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the epigenetic interface between the cell and the genome: a supplemental issue of DNA and cell biology on epigenetics.
    Kasinski AL; Pincus Z
    DNA Cell Biol; 2012 Oct; 31 Suppl 1():S1. PubMed ID: 23046452
    [No Abstract]   [Full Text] [Related]  

  • 9. Epigenetic alterations in cancer.
    Ilango S; Paital B; Jayachandran P; Padma PR; Nirmaladevi R
    Front Biosci (Landmark Ed); 2020 Mar; 25(6):1058-1109. PubMed ID: 32114424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetically Active Drugs Inhibiting DNA Methylation and Histone Deacetylation.
    Chistiakov DA; Myasoedova VA; Orekhov AN; Bobryshev YV
    Curr Pharm Des; 2017; 23(8):1167-1174. PubMed ID: 27774908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer epigenetics: Moving forward.
    Nebbioso A; Tambaro FP; Dell'Aversana C; Altucci L
    PLoS Genet; 2018 Jun; 14(6):e1007362. PubMed ID: 29879107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epigenetics in tumorigenesis: advances and clinical implications].
    Wang Xh; Zhao Xj; Qiu Lh; Wang Hq; Wang X
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Oct; 44(5):701-7. PubMed ID: 23073578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epigenetics: a novel tool for early diagnosis and tumor therapy].
    Filetici P
    Recenti Prog Med; 2015 Jan; 106(1):32-4. PubMed ID: 25621778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4.
    Xiang W; Wang Q; Ran K; Ren J; Shi Y; Yu L
    Bioorg Chem; 2021 Oct; 115():105238. PubMed ID: 34390970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.
    Brien GL; Valerio DG; Armstrong SA
    Cancer Cell; 2016 Apr; 29(4):464-476. PubMed ID: 27070701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomics: Roadmap for regulation.
    Romanoski CE; Glass CK; Stunnenberg HG; Wilson L; Almouzni G
    Nature; 2015 Feb; 518(7539):314-6. PubMed ID: 25693562
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting the epigenetic regulation of antitumour immunity.
    Hogg SJ; Beavis PA; Dawson MA; Johnstone RW
    Nat Rev Drug Discov; 2020 Nov; 19(11):776-800. PubMed ID: 32929243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshop.
    Zelent A; Petrie K; Lotan R; Waxman S; Gore SD
    Mol Cancer Ther; 2005 Nov; 4(11):1810-9. PubMed ID: 16276003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROTACs in Epigenetic Cancer Therapy: Current Status and Future Opportunities.
    Liu X; Wang A; Shi Y; Dai M; Liu M; Cai HB
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
    Pearson AD; Stegmaier K; Bourdeaut F; Reaman G; Heenen D; Meyers ML; Armstrong SA; Brown P; De Carvalho D; Jabado N; Marshall L; Rivera M; Smith M; Adamson PC; Barone A; Baumann C; Blackman S; Buenger V; Donoghue M; Duncan AD; Fox E; Gadbaw B; Hattersley M; Ho P; Jacobs I; Kelly MJ; Kieran M; Lesa G; Ligas F; Ludwinski D; McDonough J; Nikolova Z; Norga K; Senderowicz A; Taube T; Weiner S; Karres D; Vassal G
    Eur J Cancer; 2020 Nov; 139():135-148. PubMed ID: 32992153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.